J Neurol Surg A Cent Eur Neurosurg
DOI: 10.1055/s-0044-1801757
Original Article

Trends in Neurosurgical Treatment for Chronic Subdural Hematoma in Germany: A National Survey

Robert Mertens
1   Department of Neurosurgery, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
2   Berlin Institute of Health, BIH Academy, Junior Clinician Scientist Program, Charité-Universitätsmedizin Berlin, Berlin, Germany
,
Katharina Kersting
1   Department of Neurosurgery, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
,
1   Department of Neurosurgery, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
,
Peter Truckenmüller
1   Department of Neurosurgery, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
,
Anton Früh
1   Department of Neurosurgery, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
,
Peter Vajkoczy
1   Department of Neurosurgery, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
,
Lars Wessels
1   Department of Neurosurgery, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
› Institutsangaben
Funding Dr. Mertens is a participant of the BIH - Charité Junior Clinician Scientist Program that is funded by the Charité - Universitätsmedizin Berlin and the Berlin Institute of Health. All other authors did not receive any financial or nonfinancial support for authorship, research, and/or publication of this article.

Abstract

Background Chronic subdural hematoma (cSDH) is a common neurosurgical condition of growing importance due to the aging population and increasing use of antithrombotic agents. Due to the lack of guidelines, great variability is observed in the treatment of cSDH. We conducted a multicenter, nationwide survey to assess the differences in treatment across Germany in the context of surgical practices discussed in the literature.

Methods A web-based survey was designed using the REDCap electronic data capture tool hosted at the Charité – Universitätsmedizin Berlin. The survey was divided into four parts: preoperative management and indication for surgery, perioperative management of medication, surgical technique, and postoperative management. The survey was distributed to German neurosurgical departments through the newsletter of the German Society of Neurosurgery and direct e-mail contact and could be answered by one member of each department between March 1 and May 31, 2023.

Results Overall, representatives of 46 German neurosurgical departments completed the survey. Participants needed a mean time of 16:25 minutes (standard deviation [SD] ± 27:47 minutes) to complete the survey. The mean caseload of the participating departments was 1,831.5 (range: 300–6,000; SD ± 1,130.7) operations per year, including 87.8 procedures for cSDH (range: 15–300; SD ± 73.6). Evidence found in the literature regarding the performance of a burr hole craniotomy, use of a drain, passive drainage, removal of the drain 48 hours after surgery, and early mobilization after surgery was consistently implemented in the management of the surveyed departments. On the contrary, recommendations regarding the performance of surgery under local anesthesia, use of subgaleal drains, postoperative Valsalva maneuvers, and avoidance of postoperative computed tomography (CT) if possible were not universally implemented.

Conclusion This survey indicates that there is no consensus on the treatment of cSDH in Germany and that the steadily increasing evidence from clinical trials must be implemented in national and international guidelines. The development of tailored treatment strategies for older patients with multiple risk factors and comorbidities is of particular importance.

Ethical Approval

All procedures performed in this study were in accordance with the ethical standards of the Declaration of Helsinki (1964) and its later amendments or comparable ethical standards. For this type of study, no ethical approvement had to be obtained (ethics committee of the Charité University Hospital in Berlin, Germany). No patients were involved in this research.


Availability of Supporting Data

Supporting data are available upon reasonable request from the corresponding author (P.V.).


Authors' Contributions

P.V., R.M., and L.W. developed the concept and designed the study. R.M. and K.K. were responsible for data acquisition. All the author participated in data interpretation. Statistical analysis was done by R.M. and L.W. Drafting of the manuscript was done by R.M., L.W., and K.K. Critical revision of the manuscript for important intellectual content was done by all the authors.




Publikationsverlauf

Eingereicht: 06. Dezember 2023

Angenommen: 06. September 2024

Artikel online veröffentlicht:
20. Januar 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Kolias AG, Chari A, Santarius T, Hutchinson PJ. Chronic subdural haematoma: modern management and emerging therapies. Nat Rev Neurol 2014; 10 (10) 570-578
  • 2 Vacca Jr VMJ, Argento I. Chronic subdural hematoma: a common complexity. Nursing 2018; 48 (05) 24-31
  • 3 Feghali J, Yang W, Huang J. Updates in chronic subdural hematoma: epidemiology, etiology, pathogenesis, treatment, and outcome. World Neurosurg 2020; 141: 339-345
  • 4 Adhiyaman V, Asghar M, Ganeshram KN, Bhowmick BK. Chronic subdural haematoma in the elderly. Postgrad Med J 2002; 78 (916) 71-75
  • 5 Gaist D, García Rodríguez LA, Hellfritzsch M. et al. Association of antithrombotic drug use with subdural hematoma risk. JAMA 2017; 317 (08) 836-846
  • 6 Edlmann E, Giorgi-Coll S, Whitfield PC, Carpenter KLH, Hutchinson PJ. Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy. J Neuroinflammation 2017; 14 (01) 108
  • 7 Hutchinson PJ, Edlmann E, Bulters D. et al; British Neurosurgical Trainee Research Collaborative, Dex-CSDH Trial Collaborators. Trial of dexamethasone for chronic subdural hematoma. N Engl J Med 2020; 383 (27) 2616-2627
  • 8 Rauhala M, Luoto TM, Huhtala H. et al. The incidence of chronic subdural hematomas from 1990 to 2015 in a defined Finnish population. J Neurosurg 2019; 132 (04) 1147-1157
  • 9 Balser D, Farooq S, Mehmood T, Reyes M, Samadani U. Actual and projected incidence rates for chronic subdural hematomas in United States Veterans Administration and civilian populations. J Neurosurg 2015; 123 (05) 1209-1215
  • 10 Almenawer SA, Farrokhyar F, Hong C. et al. Chronic subdural hematoma management: a systematic review and meta-analysis of 34,829 patients. Ann Surg 2014; 259 (03) 449-457
  • 11 Liu W, Bakker NA, Groen RJM. Chronic subdural hematoma: a systematic review and meta-analysis of surgical procedures. J Neurosurg 2014; 121 (03) 665-673
  • 12 Duerinck J, Van Der Veken J, Schuind S. et al. Randomized trial comparing burr hole craniostomy, minicraniotomy, and twist drill craniostomy for treatment of chronic subdural hematoma. Neurosurgery 2022; 91 (02) 304-311
  • 13 Ebel F, Greuter L, Lutz K. et al. The role of active or passive drainage after evacuation of chronic subdural hematoma: an analysis of two randomized controlled trials (cSDH-drain-trial and TOSCAN trial). Diagnostics (Basel) 2022; 12 (12) 3045
  • 14 Song L, Zhou K, Wang C. et al. Comparison of subperiosteal or subgaleal drainage and subdural drainage in patients with chronic subdural hematoma: A systematic review and meta-analysis. Medicine (Baltimore) 2023; 102 (43) e35731
  • 15 Chen C, Xiong Y, Huang X. et al. Subperiosteal/subgaleal drainage vs. subdural drainage for chronic subdural hematoma: a meta-analysis of postoperative outcomes. PLoS One 2023; 18 (08) e0288872
  • 16 Pranata R, Deka H, July J. Subperiosteal versus subdural drainage after burr hole evacuation of chronic subdural hematoma: systematic review and meta-analysis. Acta Neurochir (Wien) 2020; 162 (03) 489-498
  • 17 Liu HY, Yang LL, Dai XY, Li ZP. Local anesthesia with sedation and general anesthesia for the treatment of chronic subdural hematoma: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci 2022; 26 (05) 1625-1631
  • 18 Santarius T, Kirkpatrick PJ, Ganesan D. et al. Use of drains versus no drains after burr-hole evacuation of chronic subdural haematoma: a randomised controlled trial. Lancet 2009; 374 (9695) 1067-1073
  • 19 Sousa S, Pinto V, Vaz da Silva F. et al; GET-UP Trial Collaborators. Impact of an early mobilization protocol on the reduction of medical complications after surgery for chronic subdural hematoma: the GET-UP Trial. J Neurosurg 2023; 139 (03) 854-863
  • 20 Won SY, Dubinski D, Behmanesh B. et al. Supervised Valsalva maneuver after burr hole evacuation of chronic subdural hematomas: a prospective cohort study. J Neurotrauma 2021; 38 (07) 911-917
  • 21 Zeng L, Yu J, Chen R. et al. Modified Valsalva maneuver after burr-hole drainage of chronic subdural hematomas: a single-center cohort study. Front Neurol 2023; 13: 1069708
  • 22 Schucht P, Fischer U, Fung C. et al. Follow-up computed tomography after evacuation of chronic subdural hematoma. N Engl J Med 2019; 380 (12) 1186-1187
  • 23 Mowla A, Abdollahifard S, Farrokhi A, Yousefi O, Valibeygi A, Azami P. Middle meningeal artery embolization with liquid embolic agents for chronic subdural hematoma: a systematic review and meta-analysis. J Vasc Interv Radiol 2023; 34 (09) 1493-1500.e7
  • 24 Sattari SA, Yang W, Shahbandi A. et al. Middle meningeal artery embolization versus conventional management for patients with chronic subdural hematoma: a systematic review and meta-analysis. Neurosurgery 2023; 92 (06) 1142-1154
  • 25 Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap): a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42 (02) 377-381
  • 26 Harris PA, Taylor R, Minor BL. et al; REDCap Consortium. The REDCap consortium: building an international community of software platform partners. J Biomed Inform 2019; 95: 103208
  • 27 Ducruet AF, Grobelny BT, Zacharia BE. et al. The surgical management of chronic subdural hematoma. Neurosurg Rev 2012; 35 (02) 155-169 , discussion 169
  • 28 Mascarenhas L. Illustration of the impact of antiplatelet drugs on the genesis and management of chronic subdural hematoma. Neurochirurgie 2012; 58 (01) 47-51
  • 29 Poon MTC, Rea C, Kolias AG, Brennan PM. British Neurosurgical Trainee Research Collaborative (BNTRC). Influence of antiplatelet and anticoagulant drug use on outcomes after chronic subdural hematoma drainage. J Neurotrauma 2021; 38 (08) 1177-1184
  • 30 Eun J, Ahn S, Lee MH. et al. Balancing bleeding risk and thromboembolic complications in elderly chronic subdural hematoma patients undergoing burr hole trephination: a multicenter retrospective cohort study and literature review. J Korean Neurosurg Soc 2023; 66 (06) 726-734
  • 31 Kerttula S, Huttunen J, Leinonen V, Kämäräinen OP, Danner N. The effect of antithrombotic therapy on the recurrence and outcome of chronic subdural hematoma after burr-hole craniostomy in a population-based cohort. Acta Neurochir (Wien) 2022; 164 (10) 2699-2708
  • 32 Nathan S, Goodarzi Z, Jette N, Gallagher C, Holroyd-Leduc J. Anticoagulant and antiplatelet use in seniors with chronic subdural hematoma: systematic review. Neurology 2017; 88 (20) 1889-1893
  • 33 Salih M, Young M, Shutran M. et al. Effect of long-term anticoagulant therapy on the outcome of chronic subdural hematoma: a propensity score-matched analysis. J Neurosurg 2022; 139 (01) 194-200
  • 34 Guzel A, Kaya S, Ozkan U, Ufuk Aluclu M, Ceviz A, Belen D. Surgical treatment of chronic subdural haematoma under monitored anaesthesia care. Swiss Med Wkly 2008; 138 (27–28): 398-403
  • 35 Kim SO, il Jung S, Won YS, Choi CS, Yang JY. A comparative study of local versus general anesthesia for chronic subdural hematoma in elderly patients over 60 years. Korean J Neurotrauma 2013; 9 (02) 47-51
  • 36 Seizeur R, Abed-Rabbo F, Obaid S. et al. Chronic subdural haematomas in elderly population. Neurosurgical aspects and focus on the single-burr hole technique performed under assisted local anaesthesia. Br J Neurosurg 2017; 31 (02) 258-261
  • 37 Mahmood SD, Waqas M, Baig MZ, Darbar A. Mini-craniotomy under local anesthesia for chronic subdural hematoma: an effective choice for elderly patients and for patients in a resource-strained environment. World Neurosurg 2017; 106: 676-679
  • 38 Surve RM, Bansal S, Reddy M, Philip M. Use of dexmedetomidine along with local infiltration versus general anesthesia for burr hole and evacuation of chronic subdural hematoma (CSDH). J Neurosurg Anesthesiol 2017; 29 (03) 274-280
  • 39 Mersha A, Abat S, Temesgen T, Nebyou A. Outcome of chronic subdural hematoma treated with single burr hole under local anesthesia. Ethiop J Health Sci 2020; 30 (01) 101-106
  • 40 Wong HM, Woo XL, Goh CH. et al. Chronic subdural hematoma drainage under local anesthesia with sedation versus general anesthesia and its outcome. World Neurosurg 2022; 157: e276-e285
  • 41 Certo F, Maione M, Altieri R. et al. Pros and cons of a minimally invasive percutaneous subdural drainage system for evacuation of chronic subdural hematoma under local anesthesia. Clin Neurol Neurosurg 2019; 187: 105559
  • 42 Weigel R, Schmiedek P, Krauss JK. Outcome of contemporary surgery for chronic subdural haematoma: evidence based review. J Neurol Neurosurg Psychiatry 2003; 74 (07) 937-943
  • 43 Ivamoto HS, Lemos Jr HPJ, Atallah AN. Surgical treatments for chronic subdural hematomas: a comprehensive systematic review. World Neurosurg 2016; 86: 399-418
  • 44 Huang YW, Yin XS, Li ZP. Burr hole craniostomy vs. minicraniotomy of chronic subdural hematoma: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci 2022; 26 (14) 4983-4990
  • 45 Smith MD, Kishikova L, Norris JM. Surgical management of chronic subdural haematoma: one hole or two?. Int J Surg 2012; 10 (09) 450-452
  • 46 Belkhair S, Pickett G. One versus double burr holes for treating chronic subdural hematoma meta-analysis. Can J Neurol Sci 2013; 40 (01) 56-60
  • 47 Roohollahi F, Kankam SB, Shafizadeh M, Khoshnevisan A. A prospective randomized controlled trial of the effect of the number of burr hole on chronic subdural hematoma recurrence: an institutional experience. Clin Neurol Neurosurg 2023; 226: 107624
  • 48 Soleman J, Lutz K, Schaedelin S. et al. Subperiosteal vs subdural drain after burr-hole drainage of chronic subdural hematoma: a randomized clinical trial (cSDH-drain-trial). Neurosurgery 2019; 85 (05) E825-E834
  • 49 Andersen-Ranberg NC, Debrabant B, Poulsen FR, Bergholt B, Hundsholt T, Fugleholm K. The Danish chronic subdural hematoma study-predicting recurrence of chronic subdural hematoma. Acta Neurochir (Wien) 2019; 161 (05) 885-894
  • 50 Ng S, Derraz I, Boetto J. et al. Middle meningeal artery embolization as an adjuvant treatment to surgery for symptomatic chronic subdural hematoma: a pilot study assessing hematoma volume resorption. J Neurointerv Surg 2020; 12 (07) 695-699
  • 51 McCann CP, Brandel MG, Wali AR. et al. Safety of middle meningeal artery embolization for treatment of subdural hematoma: a nationwide propensity score matched analysis. J Cerebrovasc Endovasc Neurosurg 2023; 25 (04) 380-389
  • 52 Catapano JS, Koester SW, Hanalioglu S. et al. Middle meningeal artery embolization associated with reduced chronic subdural hematoma volume and midline shift in the acute postoperative period. J Neurointerv Surg 2024; 16 (05) 478-481
  • 53 Lam A, Selvarajah D, Htike SS. et al. The efficacy of postoperative middle meningeal artery embolization on chronic subdural hematoma: a multicentered randomized controlled trial. Surg Neurol Int 2023; 14: 168
  • 54 Marcantonio ER. Delirium in hospitalized older adults. N Engl J Med 2017; 377 (15) 1456-1466
  • 55 Marcantonio ER. In the clinic. Delirium. Ann Intern Med 2011; 154 (11) ITC6 –ITC1, ITC6–ITC2, ITC6–ITC3, ITC6–ITC4, ITC6–ITC5, ITC6–ITC6, ITC6–ITC7, ITC6–ITC8, ITC6–ITC9, ITC6–ITC10, ITC6–ITC11, ITC6–ITC12, ITC6–ITC13, ITC6–ITC14, ITC6–ITC15, quiz ITC6–ITC16
  • 56 Marcantonio ER. Postoperative delirium: a 76-year-old woman with delirium following surgery. JAMA 2012; 308 (01) 73-81
  • 57 Levels of evidence. BJU Int 2011; 107 (05) 870
  • 58 Burns PB, Rohrich RJ, Chung KC. The levels of evidence and their role in evidence-based medicine. Plast Reconstr Surg 2011; 128 (01) 305-310
  • 59 von Spreckelsen N, Jung N, Telentschak S, Hampl J, Goldbrunner R, Grau S. Current treatment concepts for iatrogenic ventriculitis: a nationwide survey in Germany. Acta Neurochir (Wien) 2018; 160 (03) 505-508
  • 60 Ottenhausen M, Conrad J, Kalasauskas D, Netuka D, Ringel F. Pituitary surgery in Germany: findings from the European Pituitary Adenoma Surgery Survey. Exp Clin Endocrinol Diabetes 2023; 131 (06) 362-366
  • 61 Skardelly M, Mönch L, Roder C, Hockel K, Tatagiba MS, Ebner FH. Survey of the management of perioperative bridging of anticoagulation and antiplatelet therapy in neurosurgery. Acta Neurochir (Wien) 2018; 160 (11) 2077-2085
  • 62 Bartley A, Bartek Jr J, Jakola AS. et al. Effect of irrigation fluid temperature on recurrence in the evacuation of chronic subdural hematoma: a randomized clinical trial. JAMA Neurol 2023; 80 (01) 58-63